Omnicell (OMCL) Total Liabilities (2010 - 2026)
Omnicell's (OMCL) quarterly Total Liabilities came in at $707.3 million in Q2 2026, down 19.8% year-over-year from $881.9 million in Q2 2025, and down 5.38% quarter-over-quarter from $747.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Total Liabilities (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Total Liabilities for 17 consecutive years, with $707.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities fell 19.8% year-over-year to $707.3 million in Q2 2026; TTM through Jun 2026 was $707.3 million, a 19.8% decrease from a year earlier, with the FY2025 full-year figure at $742.9 million, down 15.35% from the prior year.
- Total Liabilities was $707.3 million for Q2 2026 at Omnicell, down from $747.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $1.1 billion in Q1 2023 and troughed at $707.3 million in Q2 2026.
- A 5-year average of $958.8 million and a median of $1.0 billion in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities advanced 19.67% in 2022 and sank 32.13% in 2025, its largest moves.
- Over 5 years, Total Liabilities stood at $1.1 billion in 2022, then slipped by 3.95% to $1.0 billion in 2023, then decreased by 15.44% to $877.6 million in 2024, then declined by 15.35% to $742.9 million in 2025, then decreased by 4.8% to $707.3 million in 2026.
- The last three Total Liabilities figures came in at $707.3 million (Q2 2026), $747.5 million (Q1 2026), and $742.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 57.45 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 2.58 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 42.46 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 23.94 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 20.04 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 3.14 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 9.50 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 3.83 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 2.38 Bn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 707.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 707.25 Mn |
| Mar 31, 2026 | 747.48 Mn |
| Dec 31, 2025 | 742.91 Mn |
| Sep 30, 2025 | 727.70 Mn |
| Jun 30, 2025 | 881.88 Mn |
| Mar 31, 2025 | 894.37 Mn |
| Dec 31, 2024 | 877.65 Mn |
| Sep 30, 2024 | 1.07 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 1.04 Bn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.08 Bn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 995.81 Mn |
| Sep 30, 2021 | 940.14 Mn |